BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 5745130)

  • 1. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference of immunological factors in the antitumoral activity of sarcolysine].
    Bonmassar E; Castagnone D; Celi ML; Melan F
    Arch Ital Patol Clin Tumori; 1968; 11(1):215-28. PubMed ID: 5745129
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
    Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
    Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histochemical study of the effect of actinomycin D and Ribonuclease on the nucleic acids in Ehrlich's ascitic cells].
    Arefolov VA; Brzheskiĭ VV
    Vestn Akad Nauk SSSR; 1966; 36(11):34-8. PubMed ID: 6002494
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes induced by actinomycin in the effect of x-rays on cells of Ehrlich's ascites tumor].
    Casanello D; Valencia JI
    Rev Soc Argent Biol; 1967; 43(1):74-83. PubMed ID: 4175932
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in nucleolar number of ascites tumor cells treated with actinomycin D.
    Gyeskó A; Holczinger L
    Neoplasma; 1975; 22(4):395-402. PubMed ID: 1196423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of actinomycin-D and ribonuclease on the synthesis and content of DNA in the cells of Ehrlich's ascites carcinoma (microspectrophotometric and autoradiographic analysis)].
    Arefolov VA
    Vestn Akad Med Nauk SSSR; 1965; 20(11):80-6. PubMed ID: 5876180
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the effect of Rantarin FM and its combination with Thio-TEPA on the transplantability and growth of Ehrlich's tumor].
    Iaremenko KV; Shishenkova NM
    Vopr Onkol; 1968; 14(2):95-6. PubMed ID: 4971178
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the subcutaneous growth of Ehrlich's ascites carcinoma in female mice by polyethylene glycol 4000.
    Hartveit F
    J Pathol; 1969 Jan; 97(1):145-8. PubMed ID: 5783629
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research on the antimitotic effect of treatment with combined pancreatic desoxyribonuclease and p-(N'-methylhydrazino-methyl)-N-iso-propyl-benzamide hydrochloride on the cells of Ehrlich's ascites tumor].
    Magliulo E; Petrocini S; Fossati GC; Gorini S
    Arch Sci Med (Torino); 1968 May; 125(5):179-84. PubMed ID: 5696482
    [No Abstract]   [Full Text] [Related]  

  • 12. The regression of Ehrlich's ascites tumour cells transplanted intraperitoneally in rats.
    Hardy D
    Arch Immunol Ther Exp (Warsz); 1969; 17(3):372-5. PubMed ID: 5802834
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB; Zhang Y; Frenkel GD
    Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the action of bleomycin using liposome with Ehrlich's ascites carcinoma in mice.
    Sur P; Roy DK
    Indian J Exp Biol; 1979 Sep; 17(9):952-3. PubMed ID: 94590
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interference of various hormonal therapy on the growth of Ehrlich's ascites tumor cells and the antitumoral activity of 5-fluorouracil].
    Melan F; Napoli PA; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(3):271-83. PubMed ID: 5737808
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice.
    Lemmel EM; Motycka K; Soucek J; Nouza K
    Arzneimittelforschung; 1967 Feb; 17(2):142-5. PubMed ID: 4173310
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
    Bergamini G; D'Acunzo L; Fazio G; Giudici G
    Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of immunological factors on the antitumor action of 4-diphenylylglioxal in Ehrlich ascites cancer].
    Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1969; 12(1):57-67. PubMed ID: 5396284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds].
    Ivanitskii LP; Makukho LV
    Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.